Invention Grant
- Patent Title: Solid forms of nilotinib hydrochloride
-
Application No.: US15518895Application Date: 2015-10-15
-
Publication No.: US10016423B2Publication Date: 2018-07-10
- Inventor: Matthew Pompili , David A. Stradiotto , Probal Kanti Datta
- Applicant: Apotex Inc.
- Applicant Address: CA Toronto, Ontario
- Assignee: Apotex Inc.
- Current Assignee: Apotex Inc.
- Current Assignee Address: CA Toronto, Ontario
- Agency: The Webb Law Firm
- International Application: PCT/CA2015/000534 WO 20151015
- International Announcement: WO2016/058081 WO 20160421
- Main IPC: A61K31/506
- IPC: A61K31/506 ; C07D401/14 ; C07C59/185 ; C07C51/41 ; A61K47/48
Abstract:
A solid form of Nilotinib hydrochloride, which exists as a co-crystal of nilotinib hydrochloride and levulinic acid having a molar ratio of nilotinib hydrochloride to levulinic acid of 1:2, and a process for the preparation of the co-crystal.
Public/Granted literature
- US20170239247A1 Solid Forms of Nilotinib Hydrochloride Public/Granted day:2017-08-24
Information query
IPC分类:
